NCT07612059

Brief Summary

This single-center randomized controlled clinical trial will evaluate the effects of structured early postpartum mother-infant skin-to-skin contact, with or without maternal lavender aromatherapy, after elective cesarean section on maternal stress biomarkers and early breastfeeding outcomes. The study will enroll 150 term pregnant women scheduled for elective cesarean section under spinal anesthesia at Ataturk University Research Hospital. Participants will be randomized into three groups: routine postoperative care, structured skin-to-skin contact, and structured skin-to-skin contact combined with inhalational lavender aromatherapy. The primary outcome is the change in maternal salivary cortisol level from immediately after birth to 60 minutes postpartum. Secondary outcomes include maternal salivary IgA levels, state anxiety scores, postoperative pain and nausea, time to first analgesic requirement, early breastfeeding initiation and success, LATCH scores, neonatal axillary temperature, cumulative duration and continuity of skin-to-skin contact, maternal satisfaction, and the need for mother-infant separation within the first 2 hours postpartum.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
19mo left

Started Jun 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
Jun 2026Dec 2027

First Submitted

Initial submission to the registry

May 21, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 28, 2026

Completed
4 days until next milestone

Study Start

First participant enrolled

June 1, 2026

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2027

Expected
Last Updated

May 28, 2026

Status Verified

May 1, 2026

Enrollment Period

Same day

First QC Date

May 21, 2026

Last Update Submit

May 21, 2026

Conditions

Keywords

Elective cesarean sectionSkin-to-skin contactLavender aromatherapySalivary cortisolImmunoglobulin A (IgA)Early breastfeedingPostoperative pain

Outcome Measures

Primary Outcomes (1)

  • Change in maternal salivary cortisol level

    Difference in maternal salivary cortisol concentration between immediately after birth (T0) and 60 minutes postpartum (T1), compared among the three study groups.

    From immediately after birth (T0) to 60 minutes postpartum (T1)

Secondary Outcomes (11)

  • Maternal salivary IgA level

    From immediately after birth (T0) to 60 minutes postpartum (T1)

  • State anxiety score (STAIS-5)

    Preoperative baseline to 120 minutes postpartum (T2)

  • Postoperative pain intensity (VAS)

    60 minutes (T1) and 120 minutes (T2) postpartum

  • Postoperative nausea and vomiting

    60 minutes (T1) and 120 minutes (T2) postpartum

  • Time to first analgesic requirement

    From end of surgery to first analgesic requirement within the first 24 hours postoperatively

  • +6 more secondary outcomes

Study Arms (3)

Routine Care

NO INTERVENTION

Participants in this arm will receive routine intraoperative and postoperative care after elective cesarean section under spinal anesthesia, according to the standard practice of Ataturk University Research Hospital. No structured early skin-to-skin contact protocol or lavender aromatherapy will be applied beyond usual care.

Structured Skin-to-Skin Contact

EXPERIMENTAL

Participants in this arm will receive a structured early postpartum mother-infant skin-to-skin contact protocol after elective cesarean section under spinal anesthesia. Following delivery and clinical stabilization of the mother and newborn, the naked neonate will be placed prone on the mother's bare chest, covered with a warm blanket, and maintained in continuous skin-to-skin contact during the first 60 minutes postpartum as tolerated. Cumulative duration of skin-to-skin contact, number of interruptions, and reasons for interruption will be recorded.

Behavioral: Structured early postpartum mother-infant skin-to-skin contact

Structured Skin-to-Skin Contact Plus Lavender Aromatherapy

EXPERIMENTAL

Participants in this arm will receive the same structured early postpartum mother-infant skin-to-skin contact protocol as in the skin-to-skin only group, combined with maternal inhalational lavender aromatherapy. Lavender essential oil will be administered via inhalation using a cotton pad or similar carrier placed near the mother's face during the early postpartum period, starting shortly after surgery and maintained during the first 60 minutes postpartum as tolerated, according to the study protocol. Tolerance to aromatherapy and any adverse reactions will be monitored and recorded.

Behavioral: Structured early postpartum mother-infant skin-to-skin contactOther: Maternal inhalational lavender aromatherapy

Interventions

A structured early postpartum skin-to-skin contact protocol applied after elective cesarean section under spinal anesthesia. Following stabilization of the mother and newborn, the naked neonate is placed prone on the mother's bare chest and covered with a warm blanket. Continuous skin-to-skin contact is maintained during the first 60 minutes postpartum as tolerated, and cumulative duration, number of interruptions, and reasons for interruption are recorded.

Structured Skin-to-Skin ContactStructured Skin-to-Skin Contact Plus Lavender Aromatherapy

Maternal inhalational aromatherapy using lavender essential oil during the early postpartum period after elective cesarean section. Lavender oil is applied via inhalation using a cotton pad or similar carrier placed near the mother's face during the first 60 minutes postpartum, in combination with the structured skin-to-skin contact protocol, as tolerated. Tolerance to aromatherapy and any adverse reactions are monitored and recorded.

Structured Skin-to-Skin Contact Plus Lavender Aromatherapy

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Female participants aged 18 to 40 years
  • Term singleton pregnancy (≥37 weeks of gestation)
  • Scheduled for elective cesarean section
  • ASA physical status I-II
  • Planned spinal anesthesia
  • Clinically stable mother and newborn immediately after birth
  • Ability to initiate breastfeeding in the early postpartum period
  • Provision of written informed consent

You may not qualify if:

  • Emergency cesarean section
  • General anesthesia or conversion from spinal to general anesthesia
  • Need for neonatal resuscitation or severe neonatal compromise
  • Maternal hemodynamic instability or massive hemorrhage
  • Major fetal congenital anomalies
  • Known allergy or intolerance to lavender
  • Severe asthma or intolerance to strong odors
  • Major psychiatric disorders
  • Serious endocrine diseases affecting stress hormone regulation
  • Clinical conditions that preclude breastfeeding
  • Contraindications to spinal anesthesia
  • Refusal to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ataturk University

Erzurum, 25240, Turkey (Türkiye)

Location

Related Publications (3)

  • Namba Y, Smith JB, Fox GS, Challis JR. Plasma cortisol concentrations during Caesarean section. Br J Anaesth. 1980 Oct;52(10):1027-32. doi: 10.1093/bja/52.10.1027.

  • Nouira M, Souayeh N, Kanzari SA, Rouis H, Lika A, Mbarki C, Rahali FZ, Bettaieb H. Aromatherapy Using Lavender Oil Effectiveness on Pain and Anxiety After C-Section: A Randomized Controlled Trial. J Epidemiol Glob Health. 2024 Dec;14(4):1536-1544. doi: 10.1007/s44197-024-00305-6. Epub 2024 Oct 14.

  • Widstrom AM, Brimdyr K, Svensson K, Cadwell K, Nissen E. Skin-to-skin contact the first hour after birth, underlying implications and clinical practice. Acta Paediatr. 2019 Jul;108(7):1192-1204. doi: 10.1111/apa.14754. Epub 2019 Mar 13.

MeSH Terms

Conditions

Breast FeedingPain, Postoperative

Condition Hierarchy (Ancestors)

Feeding BehaviorBehaviorPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • kamber kasali, PhD

    Atatürk University Faculty of Medicine, Department of Biostatistics, Erzurum, Turkey

    STUDY CHAIR
  • gamzenur cimilli senocak, MD

    Atatürk University Faculty of Medicine, Department of Obstetrics and Gynecology, Erzurum, Turkey

    STUDY CHAIR
  • orhan buyukkurt, MD

    Ataturk University Faculty of Medicine, Department of Anesthesiology and Reanimation

    STUDY CHAIR

Central Study Contacts

aysenur dostbil, MD

CONTACT

orhan buyukkurt, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Open-label to participants and care providers; laboratory personnel and statistical analysis team will be blinded to group allocation when assessing biochemical and outcome data (outcomes assessor-masked).
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Parallel assignment of three groups: routine postoperative care, structured early postpartum mother-infant skin-to-skin contact, and structured skin-to-skin contact combined with maternal inhalational lavender aromatherapy after elective cesarean section under spinal anesthesia.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Anesthesiology and Reanimation

Study Record Dates

First Submitted

May 21, 2026

First Posted

May 28, 2026

Study Start

June 1, 2026

Primary Completion

June 1, 2026

Study Completion (Estimated)

December 30, 2027

Last Updated

May 28, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

There is no current plan to share individual participant data (IPD) outside the study team due to institutional and national data protection regulations.

Locations